SCNI: Scinai Immunotherapeutics Ltd - ADR Company Profile & Statistics

About

Scinai Immunotherapeutics Ltd. is a biopharmaceutical company focused on developing, manufacturing, and commercializing inflammation and immunology biological products primarily for the treatment of autoimmune and infectious diseases. Scinai Immunotherapeutics Ltd., formerly known as BiondVax Pharmaceuticals Ltd., is based in JERUSALEM.

Info & Links

CEO

Amir Reichman

Headquarters

JERUSALEM BIOPARK, 2ND FLOOR, HADASSAH EIN KEREM CAMPUS
JERUSALEM, L3 00000, ISRAEL

Auditor

Kesselman & Kesselman

Share holders

Employees

Scinai Immunotherapeutics Ltd - ADR Statistics

Valuation Measures

Market Capitalization²

Enterprise Value

18.60M

Enterprise Value/EBITDA(ttm)

-3.31

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

0.67

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

-37.05%

Operating Margin(ttm)

Profit Margin(ttm)

1555.80%

Return on Equity(ttm)

Return on Invested Capital(ttm)

70.93%

Return on Assets(ttm)

-30.48%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

Gross Profit(ttm)

0.00

EBITDA(ttm)³

-5.61M

Net Income Available to Common(ttm)

-1.38M

Diluted EPS(ttm)

-239.17

Share Statistics

Beta (5Y Monthly)

2.43

52-Week Change

-53.41%

S&P 500 52-Week Change

26.78%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

Dividend Yield

0.00%

Float⁴

802.00K

% Held by Insiders

6.03%

% Held by Institutions

58.41%

Balance Sheet

Total Cash(mrq)

3.21M

Total Cash Per Share(mrq)

Total Debt(mrq)

19.82M

Total Debt/Equity(mrq)

2.80%

Current Ratio(mrq)

1.16%

Quick Ratio(mrq)

1.16%

Book Value Per Share(mrq)

1.17

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.62

Free Cash Flow(ytd)

-5.27M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

SCNI

Scinai Immunotherapeutics Ltd - ADR

Scinai Immunotherapeutics Ltd - ADR Profile